Effect of access to anticoagulation management services on warfarin use in patients with atrial fibrillation

Pharmacotherapy

Volumn 25, Issue 8, 2005, Pages 1062-1067

  Burkiewicz, Jill S ^a  

^a MIDWESTERN UNIVERSITY   (United States)

Author keywords

Anticoagulation; Atrial fibrillation; Prescription practices; Stroke; Warfarin

Indexed keywords

WARFARIN;

ADULT; AGED; AMBULATORY CARE; ANTICOAGULATION; ARTICLE; CONTROLLED STUDY; DRUG CONTRAINDICATION; DRUG UTILIZATION; FEMALE; HEALTH CARE ACCESS; HEALTH CARE SYSTEM; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; PHARMACIST; RETROSPECTIVE STUDY; RISK FACTOR; STROKE;

AGE FACTORS; AGED; AGED, 80 AND OVER; AMBULATORY CARE; ANTICOAGULANTS; ASPIRIN; ATRIAL FIBRILLATION; CEREBROVASCULAR ACCIDENT; DRUG UTILIZATION; FEMALE; HUMANS; ILLINOIS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; RISK FACTORS; SEX FACTORS; SPECIALISM; UNITED STATES; URBAN POPULATION; WARFARIN;

EID: 23244445929     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.2005.25.8.1062     Document Type: Article

References (18)

1. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke 1991;22:983-8.
2. Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994;154:1449-57.
3. Atrial Fibrillation Investigators. The efficacy of aspirin in patients with atrial fibrillation: analysis of pooled data from 3 randomized trials. Arch Intern Med 1997;157:1237-40.
4. Singer DE, Albers GW, Dalen JE, Go AS, Halperin JL, Manning WJ. Antithrombotic therapy in atrial fibrillation: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 2004;126:429S-56.
5. Beyth RJ, Antani MR, Covinsky KE, et al. Why isn't warfarin prescribed to patients with nonrheumatic atrial fibrillation? J Gen Intern Med 1996;11:721-8.
6. Antani MR, Beyth RJ, Covinsky KE, et al. Failure to prescribe warfarin to patients with nonrheumatic atrial fibrillation. J Gen Intern Med 1996;11:713-20.
7. Brass LM, Krumholz HM, Scinto JM, Radford M. Warfarin use among patients with atrial fibrillation. Stroke 1997;28:2382-9.
8. Stafford RS, Singer DE. National patterns of warfarin use in atrial fibrillation. Arch Intern Med 1996;156:2537-41.
9. Go AS, Hylek EM, Borowsky LH, Phillips KA, Selby JV, Singer DE. Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Ann Intern Med 1999;131:927-34.
10. Samsa GP, Matchar DB, Goldstein LB, et al. Quality of anticoagulation management among patients with atrial fibrillation: results of a review of medical records from 2 communities. Arch Intern Med 2000;160:967-73.
11. Stafford RS, Singer DE. Recent national patterns of warfarin use in atrial fibrillation. Circulation 1998;97:1231-3.
12. Johnston JA, Cluxton RJ Jr, Heaton PC, Guo JJ, Moomaw CJ, Eckman MH. Predictors of warfarin use among Ohio Medicaid patients with new-onset nonvalvular atrial fibrillation. Arch Intern Med 2003;163:1705-10.
13. Bungard TJ, Ghali WA, McAlister FA, et al. Physicians' perceptions of the benefits and risks of warfarin for patients with nonvalvular atrial fibrillation. Can Med Assoc J 2001;165:301-2.
14. Chiquette E, Amato MG, Bussey HI. Comparison of an anticoagulation clinic with usual medical care: anticoagulation control, patient outcomes, and health care costs. Arch Intern Med 1998;158:1641-7.
15. Matchar DB, Samsa GP, Cohen SJ. Should we just let the anticoagulation service do it? The conundrum of anticoagulation for atrial fibrillation [editorial]. J Gen Intern Med 1996;11:768-70.
16. Anonymous. International classification of diseases, ninth revision, clinical modification. Downers Grove, IL: Practice Management Information Corporation, 2004.
17. Copland M, Walker ID, Tait RC. Oral anticoagulation and hemorrhagic complications in an elderly population with atrial fibrillation. Arch Intern Med 2001;161:2125-8.
18. Gross CP, Vogel EW, Dhond AJ, et al. Factors influencing physicians' reported use of anticoagulation therapy in nonvalvular atrial fibrillation: a cross-sectional survey. Clin Ther 2003;25:1750-64.